Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Kini
    Junior Member
    • Apr 2016
    • 1

    Nimblegen exome, Prepairing the Hybridization Sample

    Hello everyone!

    Today I had a mistake in the lab during the hybridization step of "Nimblegen EZ Library SR" protocol.

    In the last part of it, we added the probe pool before denaturing the libraries pool.

    In the protocol it says to denature 10 minutes at 95 degrees. As far as the biotin is ligated by a covalent bound to those probes, what we did was denaturing only 3 minutes at 95 degrees and finger crossed not to loose the biotin.

    I've been reading several protocols about exome capture and in all of them goes first denaturation, then adding the probes pool. So then it has to be a very good reason to do it in this order.

    I have already writen to the customer service to know about it.

    At least we have enough libraries pool and reactives to repeat it, but we rather try not to loose the first try.

    What do you think about it?

    Thank you!
  • carolined
    Junior Member
    • Mar 2015
    • 3

    #2
    Hi Kini. I expect that you have already received your answer to this but it is ok to heat the probes to 95oC for short durations. The new SeqCap EZ Hyper Workflow User's Guide v1.0 uses a bead based method to set up the hybridization reaction. This workflow calls for you to mix the DNA libraries with the probes, heat everything to 95oC for 5 min and then cool to 47oC for the overnight hybridization.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    34 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    217 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    81 views
    0 reactions
    Last Post SEQadmin2  
    Working...